Evaluation of the Performance of the Motus Cleansing System

Evaluation of the Performance of the Motus Cleansing System

The purpose of this study is evaluate the Motus GI Colon Cleansing system performance.

Subjects indicate for colonoscopy procedure undergo a limited bowel preparation including 20 mg Bisacodyl (4*4 tables of 5 mg each) in split dose undergo standard colonoscopy with MCS.

following the procedure 2 follow-up call were conducted at 48 hours and 14 days after to the procedure.

Inclusion Criteria:

• Subjects in the age range of 18-75 years
• Subjects with BMI within the range of 18.5-35
• Subject is willing to sign informed consent form

Exclusion Criteria:

• Active or severe IBD
• Subjects with severe diverticulitis \ diverticular disease (known or detected)
• Known or detected colonic stenosis
• Known or detected bowel obstruction
• History of prior colon surgery
• ASA≥IV (sever systemic disease)
• Sever Renal insufficiency
• Sever Liver insufficiency
• Contraindication for "colonoscopy" anesthesia \ sedation \ prep agent pregnancy
• Subjects with altered mental status/inability to provide informed consent
• Subject has a condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound the study results, or may interfere significantly